Wells Fargo’s Kiora Pharmaceuticals KPRX Stock Holding History

Wells Fargo’s Portfolio KPRX Stock Details KPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-7	Closed	-$42	–	7200
2024 Q1	$42	Hold	7	–	–	﹤0.01%	6874
2023 Q4	$31	Sell	7 -6	-46%	-$31	﹤0.01%	7063
2023 Q3	$64	Buy	13 +12	+1,200%	+$61	﹤0.01%	6864
2023 Q2	$8	Hold	1	–	–	﹤0.01%	7478
2023 Q1	$37	Hold	1	–	–	﹤0.01%	7190
2022 Q4	$24	Hold	1	–	–	﹤0.01%	7239
2022 Q3	$0	Buy	+1	New	+$78	﹤0.01%	7030
2022 Q2	–	Hold	0	–	–	–	7172
2022 Q1	–	Hold	0	–	–	–	7465
2021 Q4	–	Hold	0	–	–	–	7543
2021 Q3	–	Hold	0	–	–	–	7263
2021 Q2	–	Hold	0	–	–	–	7179
2021 Q1	–	Hold	0	–	–	–	7148
2020 Q4	–	Hold	0	–	–	–	6763
2020 Q3	–	Hold	0	–	–	–	6631
2020 Q2	–	Hold	0	–	–	–	6572
2020 Q1	–	Hold	0	–	–	–	6515
2019 Q4	–	Hold	0	–	–	–	6572
2019 Q3	–	Hold	0	–	–	–	6560
2019 Q2	–	Hold	0	–	–	–	6507
2019 Q1	–	Hold	0	–	–	–	6266
2018 Q4	–	Hold	0	–	–	–	6512
2018 Q3	–	Hold	0	–	–	–	6485
2018 Q2	–	Hold	0	–	–	–	6449
2018 Q1	–	Hold	0	–	–	–	6474
2017 Q4	–	Hold	0	–	–	–	6254
2017 Q3	–	Hold	0	–	–	–	6387
2017 Q2	–	Hold	0	–	–	–	6341
2017 Q1	–	Hold	0	–	–	–	6401
2016 Q4	–	Hold	0	–	–	–	6355

Other funds holding KPRX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo's KPRX Position: Q2 2024 in Review

Wells Fargo sold out of Kiora Pharmaceuticals (KPRX) in Q2 2024, closing a stake of 7 shares — an estimated $42 sold.

Wells Fargo first reported a position in KPRX in Q3 2022 and held it in 7 quarters. The position peaked at $64 in Q3 2023. 17 funds tracked by Wall St. Rank hold KPRX as of Q2 2024.

Wells Fargo reported no remaining Kiora Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Wells Fargo sold 7 Kiora Pharmaceuticals shares in Q2 2024, an estimated $42.
Wells Fargo first reported a position in Kiora Pharmaceuticals in Q3 2022 and held it in 7 quarters.
Wells Fargo's Kiora Pharmaceuticals position peaked at $64 in Q3 2023.
17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.